SomnoMed Limited (SOM.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.30 (+3.45%) as of
Key statistics
- Market cap
- 65.93M
- Forward P/E
- 12.65
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.2300 – 0.9450
- Beta
- 0.83
- Revenue (TTM)
- 114.53M
- Profit margin
- -2.31%
- Analyst target
- A$0.83667
- Volume
- 67.23k
About SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Crows Nest, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.